|
|
||||||||
1 From the Department of Physiology, National Taiwan University, Taipei; the 2 Department of Ophthalmology, HsinChu Hospital, Taiwan; the 3 Departments of Pathology and Laboratory Medicine and 4 Ophthalmology, New York Eye and Ear Infirmary, New York, New York; and the 5 Departments of Cell Biology and 6 Ophthalmology, New York Medical College, Valhalla, New York.
PURPOSE. Brain-derived neurotrophic factor (BDNF) had a limited effect on the survival of retinal ganglion cells (RGCs) in rats eyes with elevated intraocular pressure (IOP). The combined treatment of BDNF and a nonspecific free radical scavenger N-tert-butyl-(2-sulfophenyal)-nitrone (S-PBN) was investigated on the RGCs in hypertensive eyes of rats.
METHODS. Adult Wistar rats were separated into five groups: BDNF (0.5 µg) + S-PBN; BDNF (1.0 µg) + S-PBN; BDNF (1.0 µg); S-PBN; and phosphate-buffered saline. Right eyes served as normal controls (n = 10). RGCs were labeled with 5% Fluoro Gold; injected into the superior colliculus. Three days after intratectal injection, the episcleral veins of the left eyes were cauterized. Intravitreal injection of BDNF was performed on days 5, 13, 21, and 29 after IOP elevation. S-PBN was injected intraperitoneally (100 mg/kg body wt) every 12 hours starting 30 minutes after cauterization.
RESULTS. The survival of RGCs using BDNF treatment alone in moderately hypertensive eyes and systemic administration of S-PBN alone did not significantly rescue the RGCs. However, the combination of BDNF and S-PBN increased the survival of RGCs to 90.1%.
CONCLUSIONS. Trophic factors and antioxidants have synergistic effects on rescuing RGCs from death in eyes with elevated IOP. Further studies of different combined treatment therapies may provide avenues to save RGCs from death in eyes with elevated IOP.
This article has been cited by other articles:
![]() |
M. E. Pease, D. J. Zack, C. Berlinicke, K. Bloom, F. Cone, Y. Wang, R. L. Klein, W. W. Hauswirth, and H. A. Quigley Effect of CNTF on Retinal Ganglion Cell Survival in Experimental Glaucoma Invest. Ophthalmol. Vis. Sci., May 1, 2009; 50(5): 2194 - 2200. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q.-L. Fu, B. Hu, W. Wu, R. B. Pepinsky, S. Mi, and K.-F. So Blocking LINGO-1 Function Promotes Retinal Ganglion Cell Survival Following Ocular Hypertension and Optic Nerve Transection Invest. Ophthalmol. Vis. Sci., March 1, 2008; 49(3): 975 - 985. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. B. Berry, J. M. Skarie, F. Mirzayans, Y. Fortin, T. J. Hudson, V. Raymond, B. A. Link, and M. A. Walter FOXC1 is required for cell viability and resistance to oxidative stress in the eye through the transcriptional regulation of FOXO1A Hum. Mol. Genet., February 14, 2008; 17(4): 490 - 505. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Tezel, X. Yang, and J. Cai Proteomic Identification of Oxidatively Modified Retinal Proteins in a Chronic Pressure-Induced Rat Model of Glaucoma Invest. Ophthalmol. Vis. Sci., September 1, 2005; 46(9): 3177 - 3187. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Sacca, A. Pascotto, P. Camicione, P. Capris, and A. Izzotti Oxidative DNA Damage in the Human Trabecular Meshwork: Clinical Correlation in Patients With Primary Open-Angle Glaucoma Arch Ophthalmol, April 1, 2005; 123(4): 458 - 463. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Seki, T Tanaka, H Matsuda, T Togano, K Hashimoto, J Ueda, T Fukuchi, and H Abe Topically administered timolol and dorzolamide reduce intraocular pressure and protect retinal ganglion cells in a rat experimental glaucoma model Br. J. Ophthalmol., April 1, 2005; 89(4): 504 - 507. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Tezel and X. Yang Caspase-Independent Component of Retinal Ganglion Cell Death, In Vitro Invest. Ophthalmol. Vis. Sci., November 1, 2004; 45(11): 4049 - 4059. [Abstract] [Full Text] [PDF] |
||||
![]() |
A W Siu, G G Ortiz, G Benitez-King, C H To, and R J Reiter Effects of melatonin on the nitric oxide treated retina Br. J. Ophthalmol., August 1, 2004; 88(8): 1078 - 1081. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Farkas, I. Chowers, A. S. Hackam, M. Kageyama, R. W. Nickells, D. C. Otteson, E. J. Duh, C. Wang, D. F. Valenta, T. L. Gunatilaka, et al. Increased Expression of Iron-Regulating Genes in Monkey and Human Glaucoma Invest. Ophthalmol. Vis. Sci., May 1, 2004; 45(5): 1410 - 1417. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Garcia, V. Forster, D. Hicks, and E. Vecino In Vivo Expression of Neurotrophins and Neurotrophin Receptors Is Conserved in Adult Porcine Retina In Vitro Invest. Ophthalmol. Vis. Sci., October 1, 2003; 44(10): 4532 - 4541. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Guo, P. Saloupis, S. J. Shaw, and D. W. Rickman Engraftment of Adult Neural Progenitor Cells Transplanted to Rat Retina Injured by Transient Ischemia Invest. Ophthalmol. Vis. Sci., July 1, 2003; 44(7): 3194 - 3201. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Takahata, H. Katsuki, T. Kume, D. Nakata, K. Ito, S. Muraoka, F. Yoneda, S. Kashii, Y. Honda, and A. Akaike Retinal Neuronal Death Induced by Intraocular Administration of a Nitric Oxide Donor and Its Rescue by Neurotrophic Factors in Rats Invest. Ophthalmol. Vis. Sci., April 1, 2003; 44(4): 1760 - 1766. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Garcia, V. Forster, D. Hicks, and E. Vecino Effects of Muller Glia on Cell Survival and Neuritogenesis in Adult Porcine Retina In Vitro Invest. Ophthalmol. Vis. Sci., December 1, 2002; 43(12): 3735 - 3743. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. McKinnon, D. M. Lehman, L. A. Kerrigan-Baumrind, C. A. Merges, M. E. Pease, D. F. Kerrigan, N. L. Ransom, N. G. Tahzib, H. A. Reitsamer, H. Levkovitch-Verbin, et al. Caspase Activation and Amyloid Precursor Protein Cleavage in Rat Ocular Hypertension Invest. Ophthalmol. Vis. Sci., April 1, 2002; 43(4): 1077 - 1087. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |